Objectives
- Aligning Machine Learning groups across all SIGs.
- For clinical research statisticians, where specifically are AI & ML useful – considering regulatory requirements, and where are they not useful?
- Webinars to deliver this knowledge back to industry colleagues.
Upcoming Events
No events planned currently, we are looking into webinars for the future.
Latest achievements!
Here are our latest achievements:
- Submitted comments to the FDA on the latest AI guidance with a large contribution from the data science SIG.
- Delivered a session on AI and machine learning at the 2025 PSI conference.
Topics of interest 2024
We are currently updating them.
How to get in touch
Interested in joining the AI & ML SIG?
Please send an email to Sam (sam.hadlington@plus-project.co.uk ; LinkedIn).
Who we are (as of June 2025)
The artificial intelligence and machine learning SIG is led by Sam Hadlington.
The full list of members of the AI & ML SIG can be found below:
Name | Company/Institution |
Chris Harbron | Roche |
Danila Azzolina | University of Ferrara |
Eliana Garcia Cossio | Bayer |
Emmanuel Pham | Nova In Silico |
Fabio Rigat | AstraZeneca |
Harry Parr | GSK |
Joshua Havumaki | GSK |
Karl Koechert | Bayer |
Kerry Hyland | Jazz Pharmaceuticals |
Lesedi Ledwaba-Chapman | MMS Holdings |
Nicola Hewson | AstraZeneca |
Nils Ternes | Sanofi |
Paola Berchialla | University of Turin |
Sam Hadlington | Plus-Project Partnership |
Sarah Serahati | ICON |
Tommaso Panni | Eli Lilly |
Wei Quan | AstraZeneca |